Article Details
Retrieved on: 2023-12-15 16:15:42
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Another recent arrival on the Crohn's landscape is risankizumab (Skyrizi), a monoclonal antibody that blocks the inflammatory pathway of interleukin ( ...
Article found on: www.medpagetoday.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here